Literature DB >> 21808964

Ministry of Health clinical practice guidelines: schizophrenia.

S Verma1, L L Chan, K S Chee, H Chen, S A Chin, S A Chong, W Chua, C Fones, D Fung, C L Khoo, S K D Kwek, J Ling, P Poh, K Sim, B L Tan, C Tan, C H Tan, L L Tan, W K Tay.   

Abstract

The Ministry of Health (MOH) has updated the clinical practice guidelines on Schizophrenia to provide doctors and patients in Singapore with evidence-based treatment for schizophrenia. This article reproduces the introduction and executive summary (with recommendations from the guidelines) from the MOH clinical practice guidelines on Schizophrenia, for the information of readers of the Singapore Medical Journal. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Ministry of Health website: http://www.moh.gov. sg/mohcorp/publications.aspx?id=26138. The recommendations should be used with reference to the full text of the guidelines. Following this article are multiple choice questions based on the full text of the guidelines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21808964

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  6 in total

Review 1.  A bibliometric study of scientific research conducted on second-generation antipsychotic drugs in Singapore.

Authors:  Francisco López-Muñoz; Kang Sim; Winston Wu Shen; Lorena Huelves; Raquel Moreno; Juan de Dios Molina; Gabriel Rubio; Concha Noriega; Miguel Ángel Pérez-Nieto; Cecilio Alamo
Journal:  Singapore Med J       Date:  2014-01       Impact factor: 1.858

2.  Serum Concentration of Paliperidone Palmitate Administered Every 3 Weeks.

Authors:  Johan Y Cohen; Ariane Dumoulin-Charette; Nafaa Meraabi; Raphaël Poirier
Journal:  Psychopharmacol Bull       Date:  2019-06-20

Review 3.  Diverse definitions of the early course of schizophrenia-a targeted literature review.

Authors:  Richard Newton; Alice Rouleau; Anna-Greta Nylander; Jean-Yves Loze; Henrike K Resemann; Sara Steeves; Benedicto Crespo-Facorro
Journal:  NPJ Schizophr       Date:  2018-10-15

4.  Perceived knowledge of psychiatry and family medicine residents regarding medical management of schizophrenia, hypertension, diabetes mellitus, and dyslipidemia: opportunities to refine the residency training.

Authors:  Jiangbo Ying; Jinhui Wan; Kang Sim; Ee-Jin Darren Seah; Mythily Subramaniam
Journal:  BMC Med Educ       Date:  2021-04-22       Impact factor: 2.463

Review 5.  Guidelines for Discontinuation of Antipsychotics in Patients Who Recover From First-Episode Schizophrenia Spectrum Disorders: Derived From the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review.

Authors: 
Journal:  Int J Neuropsychopharmacol       Date:  2022-09-28       Impact factor: 5.678

Review 6.  Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

Authors:  Oliver D Howes; Rob McCutcheon; Ofer Agid; Andrea de Bartolomeis; Nico J M van Beveren; Michael L Birnbaum; Michael A P Bloomfield; Rodrigo A Bressan; Robert W Buchanan; William T Carpenter; David J Castle; Leslie Citrome; Zafiris J Daskalakis; Michael Davidson; Richard J Drake; Serdar Dursun; Bjørn H Ebdrup; Helio Elkis; Peter Falkai; W Wolfgang Fleischacker; Ary Gadelha; Fiona Gaughran; Birte Y Glenthøj; Ariel Graff-Guerrero; Jaime E C Hallak; William G Honer; James Kennedy; Bruce J Kinon; Stephen M Lawrie; Jimmy Lee; F Markus Leweke; James H MacCabe; Carolyn B McNabb; Herbert Meltzer; Hans-Jürgen Möller; Shinchiro Nakajima; Christos Pantelis; Tiago Reis Marques; Gary Remington; Susan L Rossell; Bruce R Russell; Cynthia O Siu; Takefumi Suzuki; Iris E Sommer; David Taylor; Neil Thomas; Alp Üçok; Daniel Umbricht; James T R Walters; John Kane; Christoph U Correll
Journal:  Am J Psychiatry       Date:  2016-12-06       Impact factor: 18.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.